EWA
OLMA icon

EverSource Wealth Advisors’s Olema Pharmaceuticals OLMA Stock Holding History

EverSource Wealth Advisors’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.29K Buy
103
+48
+87% +$643 ﹤0.01% 3881
2026
Q1 		$820 Sell
55
-1,190
-96% -$26.5K ﹤0.01% 3921
2025
Q4 		$31.1K Buy
1,245
+1,232
+9,477% +$21.9K ﹤0.01% 2081
2025
Q3 		$127 Hold
13
– – ﹤0.01% 4166
2025
Q2 		$55 Buy
13
+4
+44% +$18 ﹤0.01% 4188
2025
Q1 		$34 Buy
+9
New +$45 ﹤0.01% 3936

Other funds holding OLMA

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
FISPB
Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

EverSource Wealth Advisors's OLMA Position: Q2 2026 in Review

EverSource Wealth Advisors increased its Olema Pharmaceuticals (OLMA) stake by 87% in Q2 2026, buying an estimated $643 and bringing the position to 103 shares worth $1.29K. The position accounts for ﹤0.01% of the portfolio, ranked #3881.

EverSource Wealth Advisors first reported a position in OLMA in Q1 2025 and has held it in 6 quarters since. The position peaked at $31.1K in Q4 2025. 29 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • EverSource Wealth Advisors held 103 shares of Olema Pharmaceuticals worth $1.29K as of Q2 2026.
  • EverSource Wealth Advisors bought 48 Olema Pharmaceuticals shares in Q2 2026, an estimated $643.
  • Olema Pharmaceuticals made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3881 holding.
  • EverSource Wealth Advisors first reported a position in Olema Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • EverSource Wealth Advisors's Olema Pharmaceuticals position peaked at $31.1K in Q4 2025.
  • 29 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.